 interferon activ latent natur killer cell alter kinet target cell lysi clinic implic oral precancer lesion reduc natur killer cell activ patient oral leukoplakia submuc fibrosi normal control subject number target lymphocyt normal precanc treatment effector cell interferon-alpha activ killer cell activ chang target bind lymphocyt count find precytotox cell interferon exist peripher blood direct recruit new cell popul place addit target lysi kinet interferon-activ killer cell tremend lytic activ statist kinet analysi natur killer cell activ import effector system immunosurveil tumor modul interferon excit clinic possibl control malign transform oral precanc